Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text: Demand for the company’s Covid vaccine has declined considerably, after generating huge sales at the height of the pandemic.
Simplified Text: Demand for the company’s Covid vaccine has declined considerably after generating huge sales at the height of the pandemic
Confidence Score: 0.900
Claim Maker: The author
Context Type: News Article
Context Details: { "vaccine_type": "Covid vaccine", "demand_status": "declined considerably" }
Subject Tags: Health
UUID: a1164c07-386c-4cba-a59a-e3a0c68826c3
Vector Index: ✗ No vector
Created: February 15, 2026 at 4:02 PM (6 months ago)
Last Updated: February 15, 2026 at 4:02 PM (6 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html

F.D.A. Rejects Moderna’s M.R.N.A. Flu Vaccine, a Sign of Policy Shift

Completed News

30 claims 🔥

1 week ago

https://nytimes.com/2026/02/10/health/fda-moderna-mrna-flu-vaccine.html

The FDA rejected Moderna's mRNA flu vaccine, signaling a shift in federal health policy under Health Secretary Robert F. Kennedy Jr. The rejection is based on concerns about the clinical trial's comparison product. Moderna's stock has plummeted since its peak.

FDA Moderna mRNA Vaccine Flu Vaccine Robert F. Kennedy Jr. Vaccine Policy Vaccine Development

Similar Claims (5)

Other claims identified as semantically similar to this one.

Perhaps no vaccine developer has been harder hit than Moderna, as federal health officials have turned against mRNA technology and some vaccines. 0.900

Simplified: Moderna has been harder hit than other vaccine developers as federal health officials have turned against mRNA technology and some vaccines

6 months ago
Moderna’s stock has plummeted by more than 90 percent since its peak in August 2021. 0.950

Simplified: Moderna’s stock has plummeted by more than 90 percent since its peak in August 2021

6 months ago
In recent years, the rate has fallen well below that critical threshold, in part because of growing vaccine hesitancy. 1.000

Simplified: Vaccination rate has fallen well below critical threshold in recent years because of growing vaccine hesitancy

6 months ago
Its flu shot was being developed for people 50 and older. 0.900

Simplified: Moderna's flu shot was being developed for people 50 and older

6 months ago
Moderna is a pioneer in using mRNA technology first with the Covid vaccine. 0.950

Simplified: Moderna is a pioneer in using mRNA technology with the Covid vaccine

6 months ago